RWE Accepted As ‘Primary Evidence’ In 20% Of NICE Appraisals Over Past Year
Executive Summary
NICE, the health technology assessment body for England and Wales, says it has seen “good uptake” of its new evaluation methods manual and real-world evidence framework, both introduced last year.
You may also be interested in...
NICE: New Proportionate Approach To HTAs ‘Flexible, But Not Bespoke’
NICE, the health technology assessment body for England and Wales, says its new proportionate approach to appraisals should be dynamic enough to “cope with the unique perspectives of new drugs” without being tailored to individual products or companies.
England: HTA Body NICE Makes Big RWE Push
England’s health technology appraisal institute, NICE, has published its real-world evidence framework.
NICE Board Approves Landmark Changes To Increase Flexibility Of Drug Evaluation Methods And Processes In England
Big changes are in store at UK health technology assessment body NICE aimed at improving the way medicines are assessed.